1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. CONCORD BIOTECH LTD.

Concord Biotech Ltd.

NSE: CONCORDBIO | BSE: 543960

Expensive Performer
Download real time

1734.00 67.10 (4.03%)

34.91% Fall from 52W High

1.4M NSE+BSE Volume

High volume today

NSE 30 May, 2025 2:41 PM (IST)

Watchlist

Portfolio

Alert

Share
17S
5W
2O
1T
18,140.4

Market Cap

Market Runner Up
48.8

PE TTM

Above industry Median
2.4

PEG TTM

PEG TTM is much higher than 1
11.4

Price to Book

High in industry
0.7

Beta 1Year

Very Low volatility
Estimates Beat
Concord Biotech's Q4 profit and revenue beat Forecaster estimates by 22.9% and 14.9%, respectively See details


Board Meetings - Concord Biotech Ltd.

The latest board meeting for Concord Biotech Ltd. took place on 29 May 2025, for the purpose of Audited Results & Final Dividend

Share
Ex-date Purpose Notes
29 May 2025 Audited Results & Final Dividend -
13 Feb 2025 Quarterly Results -
11 Nov 2024 Quarterly Results -
09 Aug 2024 Quarterly Results -
23 May 2024 Audited Results & Dividend -
08 Feb 2024 Quarterly Results -
08 Nov 2023 Quarterly Results -